Results 111 to 120 of about 8,014,776 (341)

KAPTUR: exploring the nature of visual arts research data and its effective management. [PDF]

open access: yes, 2012
KAPTUR (2011-2013), funded by JISC and led by the Visual Arts Data Service (VADS), is a highly collaborative project involving four institutional partners: the Glasgow School of Arts; Goldsmiths, University of London; University for the Creative Arts ...
Garrett, Leigh, Gramstadt, Marie-Therese
core   +2 more sources

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

Open data and the academy: an evaluation of CKAN for research data management [PDF]

open access: yes, 2013
This paper offers a full and critical evaluation of the open source CKAN software (http://ckan.org) for use as a Research Data Management (RDM) tool within a university environment.
Winn, Joss
core  

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte   +10 more
wiley   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

The State of Dissemination of Open Research Data in Ukraine and the World: Bibliometric Analysis

open access: yesEuropean Journal of Management Issues, 2021
Purpose: To determine the current state of development of open science in the paradigm of open research data in Ukraine and the world, as well as to analyze the representation of Ukraine in the world research space, in terms of research data exchange.
Anton Boiko   +2 more
doaj  

Home - About - Disclaimer - Privacy